Publication | Open Access
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial
47
Citations
18
References
2024
Year
Geometry Mono-1 TrialMedicinePathologyCancer TreatmentCancer GeneticsPhase 2OncologyCell BiologyLung CancerMolecular OncologyFinal Results
| Year | Citations | |
|---|---|---|
Page 1
Page 1